Click for best price
Active Transdermal Drug Delivery Device Market Size, Share 2022
Market Analysis and Insights: Global Active Transdermal Drug Delivery Device Market
The global Active Transdermal Drug Delivery Device market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Active Transdermal Drug Delivery Device market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Active Transdermal Drug Delivery Device market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Active Transdermal Drug Delivery Device market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Active Transdermal Drug Delivery Device market.
Global Active Transdermal Drug Delivery Device Scope and Market Size
Active Transdermal Drug Delivery Device market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Active Transdermal Drug Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Active Transdermal Drug Delivery Device market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Patches
Gels
Segment by Application
Clinic
Hospital
Home Use
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Active Transdermal Drug Delivery Device product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Active Transdermal Drug Delivery Device, with price, sales, revenue, and global market share of Active Transdermal Drug Delivery Device from 2019 to 2022.
Chapter 3, the Active Transdermal Drug Delivery Device competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Transdermal Drug Delivery Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Active Transdermal Drug Delivery Device market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Active Transdermal Drug Delivery Device.
Chapter 13, 14, and 15, to describe Active Transdermal Drug Delivery Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Active Transdermal Drug Delivery Device Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Active Transdermal Drug Delivery Device Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Active Transdermal Drug Delivery Device Product Introduction
1.2 Global Active Transdermal Drug Delivery Device Outlook 2017 VS 2022 VS 2028
1.2.1 Global Active Transdermal Drug Delivery Device Sales in US$ Million for the Year 2017-2028
1.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume for the Year 2017-2028
1.3 United States Active Transdermal Drug Delivery Device Outlook 2017 VS 2022 VS 2028
1.3.1 United States Active Transdermal Drug Delivery Device Sales in US$ Million for the Year 2017-2028
1.3.2 United States Active Transdermal Drug Delivery Device Sales in Volume for the Year 2017-2028
1.4 Active Transdermal Drug Delivery Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Active Transdermal Drug Delivery Device in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Active Transdermal Drug Delivery Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Active Transdermal Drug Delivery Device Market Dynamics
1.5.1 Active Transdermal Drug Delivery Device Industry Trends
1.5.2 Active Transdermal Drug Delivery Device Market Drivers
1.5.3 Active Transdermal Drug Delivery Device Market Challenges
1.5.4 Active Transdermal Drug Delivery Device Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Active Transdermal Drug Delivery Device Market Segment by Type
2.1.1 Patches
2.1.2 Gels
2.2 Global Active Transdermal Drug Delivery Device Market Size by Type
2.2.1 Global Active Transdermal Drug Delivery Device Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Active Transdermal Drug Delivery Device Market Size by Type
2.3.1 United States Active Transdermal Drug Delivery Device Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Active Transdermal Drug Delivery Device Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Active Transdermal Drug Delivery Device Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Home Use
3.2 Global Active Transdermal Drug Delivery Device Market Size by Application
3.2.1 Global Active Transdermal Drug Delivery Device Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Active Transdermal Drug Delivery Device Market Size by Application
3.3.1 United States Active Transdermal Drug Delivery Device Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Active Transdermal Drug Delivery Device Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Active Transdermal Drug Delivery Device Competitor Landscape by Company
4.1 Global Active Transdermal Drug Delivery Device Market Size by Company
4.1.1 Top Global Active Transdermal Drug Delivery Device Manufacturers Ranked by Revenue (2021)
4.1.2 Global Active Transdermal Drug Delivery Device Revenue by Manufacturer (2017-2022)
4.1.3 Global Active Transdermal Drug Delivery Device Sales by Manufacturer (2017-2022)
4.1.4 Global Active Transdermal Drug Delivery Device Price by Manufacturer (2017-2022)
4.2 Global Active Transdermal Drug Delivery Device Concentration Ratio (CR)
4.2.1 Active Transdermal Drug Delivery Device Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Active Transdermal Drug Delivery Device in 2021
4.2.3 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Active Transdermal Drug Delivery Device Manufacturing Base Distribution, Product Type
4.3.1 Global Active Transdermal Drug Delivery Device Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Active Transdermal Drug Delivery Device Product Type
4.3.3 Date of International Manufacturers Enter into Active Transdermal Drug Delivery Device Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Active Transdermal Drug Delivery Device Market Size by Company
4.5.1 Top Active Transdermal Drug Delivery Device Players in United States, Ranked by Revenue (2021)
4.5.2 United States Active Transdermal Drug Delivery Device Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Active Transdermal Drug Delivery Device Sales by Players (2020, 2021 & 2022)
5 Global Active Transdermal Drug Delivery Device Market Size by Region
5.1 Global Active Transdermal Drug Delivery Device Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Active Transdermal Drug Delivery Device Market Size in Volume by Region (2017-2028)
5.2.1 Global Active Transdermal Drug Delivery Device Sales in Volume by Region: 2017-2022
5.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume Forecast by Region (2023-2028)
5.3 Global Active Transdermal Drug Delivery Device Market Size in Value by Region (2017-2028)
5.3.1 Global Active Transdermal Drug Delivery Device Sales in Value by Region: 2017-2022
5.3.2 Global Active Transdermal Drug Delivery Device Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.1.2 North America Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Active Transdermal Drug Delivery Device Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.3.2 Europe Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.4.2 Latin America Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporation Information
7.1.2 Novartis AG Description and Business Overview
7.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis AG Active Transdermal Drug Delivery Device Products Offered
7.1.5 Novartis AG Recent Development
7.2 Noven Pharmaceuticals, Inc.
7.2.1 Noven Pharmaceuticals, Inc. Corporation Information
7.2.2 Noven Pharmaceuticals, Inc. Description and Business Overview
7.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Products Offered
7.2.5 Noven Pharmaceuticals, Inc. Recent Development
7.3 Transdermal Corp.
7.3.1 Transdermal Corp. Corporation Information
7.3.2 Transdermal Corp. Description and Business Overview
7.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Products Offered
7.3.5 Transdermal Corp. Recent Development
7.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
7.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
7.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Products Offered
7.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporation Information
7.5.2 Mylan N.V. Description and Business Overview
7.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Products Offered
7.5.5 Mylan N.V. Recent Development
7.6 3M
7.6.1 3M Corporation Information
7.6.2 3M Description and Business Overview
7.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.6.4 3M Active Transdermal Drug Delivery Device Products Offered
7.6.5 3M Recent Development
7.7 Actavis, Inc.
7.7.1 Actavis, Inc. Corporation Information
7.7.2 Actavis, Inc. Description and Business Overview
7.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Products Offered
7.7.5 Actavis, Inc. Recent Development
7.8 Bayer AG
7.8.1 Bayer AG Corporation Information
7.8.2 Bayer AG Description and Business Overview
7.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bayer AG Active Transdermal Drug Delivery Device Products Offered
7.8.5 Bayer AG Recent Development
7.9 Boehringer Ingelheim GmbH
7.9.1 Boehringer Ingelheim GmbH Corporation Information
7.9.2 Boehringer Ingelheim GmbH Description and Business Overview
7.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Products Offered
7.9.5 Boehringer Ingelheim GmbH Recent Development
7.10 Corium International, Inc.
7.10.1 Corium International, Inc. Corporation Information
7.10.2 Corium International, Inc. Description and Business Overview
7.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Products Offered
7.10.5 Corium International, Inc. Recent Development
7.11 Echo Therapeutics, Inc.
7.11.1 Echo Therapeutics, Inc. Corporation Information
7.11.2 Echo Therapeutics, Inc. Description and Business Overview
7.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Products Offered
7.11.5 Echo Therapeutics, Inc. Recent Development
7.12 GlaxoSmithKline plc
7.12.1 GlaxoSmithKline plc Corporation Information
7.12.2 GlaxoSmithKline plc Description and Business Overview
7.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GlaxoSmithKline plc Products Offered
7.12.5 GlaxoSmithKline plc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Active Transdermal Drug Delivery Device Industry Chain Analysis
8.2 Active Transdermal Drug Delivery Device Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Active Transdermal Drug Delivery Device Distributors
8.3 Active Transdermal Drug Delivery Device Production Mode & Process
8.4 Active Transdermal Drug Delivery Device Sales and Marketing
8.4.1 Active Transdermal Drug Delivery Device Sales Channels
8.4.2 Active Transdermal Drug Delivery Device Distributors
8.5 Active Transdermal Drug Delivery Device Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Active Transdermal Drug Delivery Device CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Active Transdermal Drug Delivery Device Market Trends
Table 3. Active Transdermal Drug Delivery Device Market Drivers
Table 4. Active Transdermal Drug Delivery Device Market Challenges
Table 5. Active Transdermal Drug Delivery Device Market Restraints
Table 6. Global Active Transdermal Drug Delivery Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Active Transdermal Drug Delivery Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Active Transdermal Drug Delivery Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Active Transdermal Drug Delivery Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Active Transdermal Drug Delivery Device Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Active Transdermal Drug Delivery Device Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Active Transdermal Drug Delivery Device Revenue Share by Manufacturer, 2017-2022
Table 13. Global Active Transdermal Drug Delivery Device Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Active Transdermal Drug Delivery Device Sales Share by Manufacturer, 2017-2022
Table 15. Global Active Transdermal Drug Delivery Device Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Active Transdermal Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Active Transdermal Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Transdermal Drug Delivery Device as of 2021)
Table 18. Top Players of Active Transdermal Drug Delivery Device in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Active Transdermal Drug Delivery Device Product Type
Table 20. Date of International Manufacturers Enter into Active Transdermal Drug Delivery Device Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Active Transdermal Drug Delivery Device Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Active Transdermal Drug Delivery Device Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Active Transdermal Drug Delivery Device Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Active Transdermal Drug Delivery Device Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Active Transdermal Drug Delivery Device Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Active Transdermal Drug Delivery Device Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Active Transdermal Drug Delivery Device Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Active Transdermal Drug Delivery Device Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Active Transdermal Drug Delivery Device Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Active Transdermal Drug Delivery Device Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Active Transdermal Drug Delivery Device Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Active Transdermal Drug Delivery Device Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Active Transdermal Drug Delivery Device Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Active Transdermal Drug Delivery Device Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Active Transdermal Drug Delivery Device Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Active Transdermal Drug Delivery Device Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Active Transdermal Drug Delivery Device Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Active Transdermal Drug Delivery Device Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Active Transdermal Drug Delivery Device Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Active Transdermal Drug Delivery Device Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novartis AG Corporation Information
Table 43. Novartis AG Description and Business Overview
Table 44. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Novartis AG Active Transdermal Drug Delivery Device Product
Table 46. Novartis AG Recent Development
Table 47. Noven Pharmaceuticals, Inc. Corporation Information
Table 48. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 49. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Noven Pharmaceuticals, Inc. Product
Table 51. Noven Pharmaceuticals, Inc. Recent Development
Table 52. Transdermal Corp. Corporation Information
Table 53. Transdermal Corp. Description and Business Overview
Table 54. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Transdermal Corp. Product
Table 56. Transdermal Corp. Recent Development
Table 57. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 58. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 59. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product
Table 61. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table 62. Mylan N.V. Corporation Information
Table 63. Mylan N.V. Description and Business Overview
Table 64. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Mylan N.V. Product
Table 66. Mylan N.V. Recent Development
Table 67. 3M Corporation Information
Table 68. 3M Description and Business Overview
Table 69. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. 3M Product
Table 71. 3M Recent Development
Table 72. Actavis, Inc. Corporation Information
Table 73. Actavis, Inc. Description and Business Overview
Table 74. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Actavis, Inc. Product
Table 76. Actavis, Inc. Recent Development
Table 77. Bayer AG Corporation Information
Table 78. Bayer AG Description and Business Overview
Table 79. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Bayer AG Product
Table 81. Bayer AG Recent Development
Table 82. Boehringer Ingelheim GmbH Corporation Information
Table 83. Boehringer Ingelheim GmbH Description and Business Overview
Table 84. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Boehringer Ingelheim GmbH Product
Table 86. Boehringer Ingelheim GmbH Recent Development
Table 87. Corium International, Inc. Corporation Information
Table 88. Corium International, Inc. Description and Business Overview
Table 89. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Corium International, Inc. Product
Table 91. Corium International, Inc. Recent Development
Table 92. Echo Therapeutics, Inc. Corporation Information
Table 93. Echo Therapeutics, Inc. Description and Business Overview
Table 94. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Echo Therapeutics, Inc. Product
Table 96. Echo Therapeutics, Inc. Recent Development
Table 97. GlaxoSmithKline plc Corporation Information
Table 98. GlaxoSmithKline plc Description and Business Overview
Table 99. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. GlaxoSmithKline plc Product
Table 101. GlaxoSmithKline plc Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Active Transdermal Drug Delivery Device Customers List
Table 105. Active Transdermal Drug Delivery Device Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Transdermal Drug Delivery Device Product Picture
Figure 2. Global Active Transdermal Drug Delivery Device Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Active Transdermal Drug Delivery Device Market Size 2017-2028 (US$ Million)
Figure 4. Global Active Transdermal Drug Delivery Device Sales 2017-2028 (K Units)
Figure 5. United States Active Transdermal Drug Delivery Device Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Active Transdermal Drug Delivery Device Market Size 2017-2028 (US$ Million)
Figure 7. United States Active Transdermal Drug Delivery Device Sales 2017-2028 (K Units)
Figure 8. United States Active Transdermal Drug Delivery Device Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Active Transdermal Drug Delivery Device Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Active Transdermal Drug Delivery Device Report Years Considered
Figure 11. Product Picture of Patches
Figure 12. Product Picture of Gels
Figure 13. Global Active Transdermal Drug Delivery Device Market Share by Type in 2022 & 2028
Figure 14. Global Active Transdermal Drug Delivery Device Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Active Transdermal Drug Delivery Device Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Active Transdermal Drug Delivery Device Sales by Type (2017-2028) & (K Units)
Figure 17. Global Active Transdermal Drug Delivery Device Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Active Transdermal Drug Delivery Device Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Active Transdermal Drug Delivery Device Market Share by Type in 2022 & 2028
Figure 20. United States Active Transdermal Drug Delivery Device Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Active Transdermal Drug Delivery Device Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Active Transdermal Drug Delivery Device Sales by Type (2017-2028) & (K Units)
Figure 23. United States Active Transdermal Drug Delivery Device Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Active Transdermal Drug Delivery Device Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Clinic
Figure 26. Product Picture of Hospital
Figure 27. Product Picture of Home Use
Figure 28. Global Active Transdermal Drug Delivery Device Market Share by Application in 2022 & 2028
Figure 29. Global Active Transdermal Drug Delivery Device Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Active Transdermal Drug Delivery Device Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Active Transdermal Drug Delivery Device Sales by Application (2017-2028) & (K Units)
Figure 32. Global Active Transdermal Drug Delivery Device Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Active Transdermal Drug Delivery Device Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States Active Transdermal Drug Delivery Device Market Share by Application in 2022 & 2028
Figure 35. United States Active Transdermal Drug Delivery Device Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Active Transdermal Drug Delivery Device Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Active Transdermal Drug Delivery Device Sales by Application (2017-2028) & (K Units)
Figure 38. United States Active Transdermal Drug Delivery Device Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Active Transdermal Drug Delivery Device Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Active Transdermal Drug Delivery Device Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Active Transdermal Drug Delivery Device Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Active Transdermal Drug Delivery Device Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Active Transdermal Drug Delivery Device Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Active Transdermal Drug Delivery Device Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Active Transdermal Drug Delivery Device Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Active Transdermal Drug Delivery Device Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 64. Latin America Active Transdermal Drug Delivery Device Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Active Transdermal Drug Delivery Device Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Middle East & Africa Active Transdermal Drug Delivery Device Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Active Transdermal Drug Delivery Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Active Transdermal Drug Delivery Device Value Chain
Figure 74. Active Transdermal Drug Delivery Device Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
